UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039392
Receipt number R000044915
Scientific Title Clinical study on the effect of continuous intake of Lactobacillus salivarius WB21 on maintaining the health of tissues around dental implants
Date of disclosure of the study information 2022/03/31
Last modified on 2023/08/09 09:07:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study on the effect of lactic acid bacterium WB21 on prognosis of dental implant

Acronym

Effect of lactic acid bacterium WB21 on prognosis of dental implant

Scientific Title

Clinical study on the effect of continuous intake of Lactobacillus salivarius WB21 on maintaining the health of tissues around dental implants

Scientific Title:Acronym

Effect of continuous intake of Lactobacillus salivarius WB21 on tissues around dental implants

Region

Japan


Condition

Condition

Dental outpatient with dental implant

Classification by specialty

Dental medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In order to maintain and promote the health of tissues around dental implants, we investigate whether continuous ingestion of lactic acid bacteria Lactobacillus salivarius WB21, which has been reported to suppress periodontitis and bad breath, can control inflammation around implants.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Implant site plaque index (PlI), gingival inflammation index (MGI), periodontal pocket (PPD), probing bleeding (BOP), secretory IgA in saliva

Key secondary outcomes

Questionnaire survey


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Licking without chewing Lactobacillus salivarius WB21 tablet after eating and oral cleaning, 3 times a day, 1 tablet at a time.

Interventions/Control_2

Licking without chewing placebo tablet after eating and oral cleaning, 3 times a day, 1 tablet at a time.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients undergoing implant treatment for molars at the Department of Oral Implantology, Fukuoka Dental College Medical and Dental Hospital, and currently undergoing maintenance

Key exclusion criteria

(1) Allergy to dairy products
(2) Persons with poor general condition
(3) Person who smokes habitually
(4) Alcoholics
(5) Pregnant and nursing women
(6) Those who took antibiotics within 3 months
(7) Others who are deemed inappropriate by the researcher

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Nao
Middle name
Last name Taniguchi

Organization

Fukuoka Dental College

Division name

Department of Preventive and Public Health Dentistry

Zip code

814-0193

Address

2-15-1 Tamura Sawara-ku, Fukuoka

TEL

092-801-0411

Email

naojsz@college.fdcnet.ac.jp


Public contact

Name of contact person

1st name Nao
Middle name
Last name Taniguchi

Organization

Fukuoka Dental College

Division name

Department of Preventive and Public Health Dentistry

Zip code

814-0193

Address

2-15-1 Tamura Sawara-ku, Fukuoka

TEL

092-801-0411

Homepage URL


Email

naojsz@college.fdcnet.ac.jp


Sponsor or person

Institute

Fukuoka Dental College

Institute

Department

Personal name



Funding Source

Organization

Fukuoka Gakuen

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka Dental University General Affairs Division

Address

2-15-1 Tamura Sawara-ku, Fukuoka

Tel

092-801-0411

Email

shomu@college.fdcnet.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

23

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

The manuscript is currently being written and is yet to be submitted.

Date of the first journal publication of results

2024 Year 03 Month 30 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 04 Month 01 Day

Date of IRB

2020 Year 01 Month 18 Day

Anticipated trial start date

2020 Year 04 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 05 Day

Last modified on

2023 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044915